Skip to main content
Caplight Logo









IntegriCulture

IntegriCulture

Private
TokyoHealthcare & Life Scienceshttps://integriculture.com/

Last Round

Debt

Aug 1, 2025

Est. Valuation

$39M

Total Funding Raised

$33.63M

Company Overview

IntegriCulture is a biotechnology company that develops and provides a cellular agriculture technology platform, the CulNet System, for applications in food, cosmetics, and other biological products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Fashion & Beauty, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts, Marketplace Commission

AI Layer

Non-AI

Keywords

cellular agriculturecell culture platformlow-cost cell culturebiotech infrastructurecultivated meatlab-grown meatcell agFBS-free culture mediumserum-free mediaCRDMOcontract researchbioreactorcosmetic ingredientsgrowth factorspicks and shovelsB2B marketplace

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IntegriCulture Comparables

Compare IntegriCulture with similar companies based on industry and business-model similarity.

IntegriCulture comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biftek
78%
Newform Foods
77%
Multus Biotechnology
77%

IntegriCulture Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtAug 1, 2025
DebtNov 7, 2024
GrantDec 29, 2023
Series A ExtensionJan 20, 2022
GrantAug 27, 2020
Series A
May 25, 2020

Key People

Founding team and executive leadership

Yuki Hanyu

Founder, CEO

Founding Team

Ikko Kawashima

CTO

Executive Team

IntegriCulture Investors

Notable investors and investment history

IntegriCulture investors
InvestorRounds
Iyogin Capital Company LimitedSeries A Extension
kemuri venturesSeries A Extension
Plan Do See Inc.Series A Extension
Future Food FundSeries A Extension
Beyond Next VenturesSeed, Series A Extension, Series A
VU Venture PartnersSeries A, Series A Extension
AgFunderSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Grew 19% QoQ, from 16 to 19 employees.

  • Sep 2, 2025

    Developing cosmetics using fish cell culture with Umami Bioworks.

IntegriCulture Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

IntegriCulture Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IntegriCulture's valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range19
Year Founded2015
Last FundingAug 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?